Hyperbaric oxygen for skin healing after breast cancer surgery
Part of Cancer, Injuries & trauma clinical trials.
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can help heal skin flaps that are not getting enough blood after breast cancer surgery. It may prevent tissue death and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 60.
- You have had breast cancer surgery and your doctor says you have mild to moderate skin damage (graded B-D and area 1-3 on a skin healing scale).
- You are in fairly good general health (ECOG score 0-2, meaning you can do daily activities).
- You are willing to sign a consent form and follow the study procedures.
- You do not have serious lung disease, ear problems, or eye conditions that would make hyperbaric oxygen unsafe.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special light-based device to measure oxygen levels in the tissue of skin flaps during plastic surgery. It aims to help doctors monitor blood flow and improve surgical outcomes.
This trial tests a device that measures oxygen levels in skin flaps used during reconstructive surgery. It may help doctors ensure the flap is healing well after surgery on an arm or leg.
This trial tests adding hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy for breast cancer. The goal is to see if it helps shrink the tumor more effectively before surgery.
This trial tests if adding hyperbaric oxygen (breathing pure oxygen in a high-pressure chamber) to standard pre-surgery treatment can help women with triple-negative or HER2-positive breast cancer. The goal is to see if it makes treatment work better and is safe.
This study tests adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard neoadjuvant therapy (treatment before surgery) for people with hormone receptor positive breast cancer. The goal is to see if it helps shrink tumors more effectively while being safe.
This trial tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen) can prevent lung inflammation caused by breast cancer radiation. It may help reduce the risk of radiation pneumonitis in certain breast cancer survivors.
Hear when a new Flap Necrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.